Pathways Knowlegdes

Necessitatibus eius consequatur ex aliquid fuga eum quidem sint consectetur velit

Pathway DOIs Note
Metabolism

Accession ID: Reactome:R-BTA-1430728		 -
Metabolism

Accession ID: Reactome:R-CFA-1430728		 -
Phase II - Conjugation of compounds

Accession ID: Reactome:R-CFA-156580
  • 10.1124/jpet.300.2.361
 McCarver DG, Hines RN. The Ontogeny of Human Drug-Metabolizing Enzymes: Phase II Conjugation Enzymes and Regulatory Mechanisms. The Journal of Pharmacology and Experimental Therapeutics. 2002 Feb;300(2):361–6. doi: 10.1124/jpet.300.2.361.
Phase II - Conjugation of compounds

Accession ID: Reactome:R-GGA-156580
  • 10.1124/jpet.300.2.361
 McCarver DG, Hines RN. The Ontogeny of Human Drug-Metabolizing Enzymes: Phase II Conjugation Enzymes and Regulatory Mechanisms. The Journal of Pharmacology and Experimental Therapeutics. 2002 Feb;300(2):361–6. doi: 10.1124/jpet.300.2.361.
Biological oxidations

Accession ID: Reactome:R-HSA-211859		 -
Glucuronidation

Accession ID: Reactome:R-HSA-156588
  • 10.1124/dmd.32.3.281
  • 10.1146/annurev.pharmtox.40.1.581
 Wells PG, Mackenzie PI, Roy Chowdhury J, Guillemette C, Gregory PA, Ishii Y, Hansen AJ, Kessler FK, Kim PM, Roy Chowdhury N, Ritter JK. GLUCURONIDATION AND THE UDP-GLUCURONOSYLTRANSFERASES IN HEALTH AND DISEASE. Drug Metabolism and Disposition. 2004 Mar;32(3):281–90. doi: 10.1124/dmd.32.3.281.; Tukey RH, Strassburg CP. Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu Rev Pharmacol Toxicol. 2000;40():581–616. doi: 10.1146/annurev.pharmtox.40.1.581. PMID: 10836148.
Metabolism

Accession ID: Reactome:R-MMU-1430728		 -
Biological oxidations

Accession ID: Reactome:R-MMU-211859		 -
Glucuronidation

Accession ID: Reactome:R-MMU-156588
  • 10.1124/dmd.32.3.281
  • 10.1146/annurev.pharmtox.40.1.581
 Wells PG, Mackenzie PI, Roy Chowdhury J, Guillemette C, Gregory PA, Ishii Y, Hansen AJ, Kessler FK, Kim PM, Roy Chowdhury N, Ritter JK. GLUCURONIDATION AND THE UDP-GLUCURONOSYLTRANSFERASES IN HEALTH AND DISEASE. Drug Metabolism and Disposition. 2004 Mar;32(3):281–90. doi: 10.1124/dmd.32.3.281.; Tukey RH, Strassburg CP. Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu Rev Pharmacol Toxicol. 2000;40():581–616. doi: 10.1146/annurev.pharmtox.40.1.581. PMID: 10836148.
Biological oxidations

Accession ID: Reactome:R-BTA-211859		 -
Glucuronidation

Accession ID: Reactome:R-BTA-156588
  • 10.1124/dmd.32.3.281
  • 10.1146/annurev.pharmtox.40.1.581
 Wells PG, Mackenzie PI, Roy Chowdhury J, Guillemette C, Gregory PA, Ishii Y, Hansen AJ, Kessler FK, Kim PM, Roy Chowdhury N, Ritter JK. GLUCURONIDATION AND THE UDP-GLUCURONOSYLTRANSFERASES IN HEALTH AND DISEASE. Drug Metabolism and Disposition. 2004 Mar;32(3):281–90. doi: 10.1124/dmd.32.3.281.; Tukey RH, Strassburg CP. Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu Rev Pharmacol Toxicol. 2000;40():581–616. doi: 10.1146/annurev.pharmtox.40.1.581. PMID: 10836148.
Phase II - Conjugation of compounds

Accession ID: Reactome:R-HSA-156580
  • 10.1124/jpet.300.2.361
 McCarver DG, Hines RN. The Ontogeny of Human Drug-Metabolizing Enzymes: Phase II Conjugation Enzymes and Regulatory Mechanisms. The Journal of Pharmacology and Experimental Therapeutics. 2002 Feb;300(2):361–6. doi: 10.1124/jpet.300.2.361.
Phase II - Conjugation of compounds

Accession ID: Reactome:R-MMU-156580
  • 10.1124/jpet.300.2.361
 McCarver DG, Hines RN. The Ontogeny of Human Drug-Metabolizing Enzymes: Phase II Conjugation Enzymes and Regulatory Mechanisms. The Journal of Pharmacology and Experimental Therapeutics. 2002 Feb;300(2):361–6. doi: 10.1124/jpet.300.2.361.
Biological oxidations

Accession ID: Reactome:R-RNO-211859		 -
Glucuronidation

Accession ID: Reactome:R-RNO-156588
  • 10.1124/dmd.32.3.281
  • 10.1146/annurev.pharmtox.40.1.581
 Wells PG, Mackenzie PI, Roy Chowdhury J, Guillemette C, Gregory PA, Ishii Y, Hansen AJ, Kessler FK, Kim PM, Roy Chowdhury N, Ritter JK. GLUCURONIDATION AND THE UDP-GLUCURONOSYLTRANSFERASES IN HEALTH AND DISEASE. Drug Metabolism and Disposition. 2004 Mar;32(3):281–90. doi: 10.1124/dmd.32.3.281.; Tukey RH, Strassburg CP. Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu Rev Pharmacol Toxicol. 2000;40():581–616. doi: 10.1146/annurev.pharmtox.40.1.581. PMID: 10836148.
Metabolism

Accession ID: Reactome:R-SSC-1430728		 -
Biological oxidations

Accession ID: Reactome:R-SSC-211859		 -
Glucuronidation

Accession ID: Reactome:R-SSC-156588
  • 10.1124/dmd.32.3.281
  • 10.1146/annurev.pharmtox.40.1.581
 Wells PG, Mackenzie PI, Roy Chowdhury J, Guillemette C, Gregory PA, Ishii Y, Hansen AJ, Kessler FK, Kim PM, Roy Chowdhury N, Ritter JK. GLUCURONIDATION AND THE UDP-GLUCURONOSYLTRANSFERASES IN HEALTH AND DISEASE. Drug Metabolism and Disposition. 2004 Mar;32(3):281–90. doi: 10.1124/dmd.32.3.281.; Tukey RH, Strassburg CP. Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu Rev Pharmacol Toxicol. 2000;40():581–616. doi: 10.1146/annurev.pharmtox.40.1.581. PMID: 10836148.
Biological oxidations

Accession ID: Reactome:R-CFA-211859		 -
Glucuronidation

Accession ID: Reactome:R-CFA-156588
  • 10.1124/dmd.32.3.281
  • 10.1146/annurev.pharmtox.40.1.581
 Wells PG, Mackenzie PI, Roy Chowdhury J, Guillemette C, Gregory PA, Ishii Y, Hansen AJ, Kessler FK, Kim PM, Roy Chowdhury N, Ritter JK. GLUCURONIDATION AND THE UDP-GLUCURONOSYLTRANSFERASES IN HEALTH AND DISEASE. Drug Metabolism and Disposition. 2004 Mar;32(3):281–90. doi: 10.1124/dmd.32.3.281.; Tukey RH, Strassburg CP. Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu Rev Pharmacol Toxicol. 2000;40():581–616. doi: 10.1146/annurev.pharmtox.40.1.581. PMID: 10836148.